These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 8769189)
21. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application? Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211 [No Abstract] [Full Text] [Related]
22. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group. Hoyer PF Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758 [TBL] [Abstract][Full Text] [Related]
23. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients. Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302 [No Abstract] [Full Text] [Related]
24. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral. Vathsala A; Lee WT; Jacob E; Woo KT Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678 [No Abstract] [Full Text] [Related]
32. Safety and tolerability of Neoral in transplant recipients. Feutren G; Wong R; Jin J; Niese D; Mellein B Transplant Proc; 1996 Aug; 28(4):2177-82. PubMed ID: 8769193 [No Abstract] [Full Text] [Related]
33. Use of cyclosporine microemulsion (Neoral) in de novo and stable renal transplantation: clinical impact, pharmacokinetic consequences and economic benefits. Canadian and International Neoral Study Groups. Keown PA Transplant Proc; 1996 Aug; 28(4):2147-50. PubMed ID: 8769183 [TBL] [Abstract][Full Text] [Related]
34. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center. Cossu M; Satta R; Branca GF; Pala PG; Serra G; Satta RP; Sorba G Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271 [No Abstract] [Full Text] [Related]
35. The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients. Kahan BD; Dunn J; Fitts C; Van Buren D; Wombolt D; Pollak R; Carson R; Alexander JW; Chang C; Choc M Transplant Proc; 1994 Oct; 26(5):2940-3. PubMed ID: 7940928 [No Abstract] [Full Text] [Related]
36. Comparative pharmacokinetic study of neoral versus Sandimmun in Japanese stable renal allograft recipients. Takahara S; Ohta K; Ohashi Y; Namii Y; Uchida K; Okuyama A; Kainuma H; Takagi H; Takahashi K; Morikawa H Transplant Proc; 2001 Jun; 33(4):2541-4. PubMed ID: 11406243 [No Abstract] [Full Text] [Related]
37. Comparative pharmacokinetic study of Neoral vs Sandimmun in Japanese stable renal allograft recipients. Takahara S; Ohta K; Ohashi Y; Namii Y; Uchida K; Okuyama A; Kainuma H; Takagi H; Takahashi K; Morikawa H Transplant Proc; 1999 Nov; 31(7):3089-92. PubMed ID: 10610595 [No Abstract] [Full Text] [Related]
38. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients? Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945 [TBL] [Abstract][Full Text] [Related]
39. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral). Foradori A; Pinto VM; Elberg A Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235 [No Abstract] [Full Text] [Related]
40. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients. Roth D; Miller J Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]